This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Furthermore, government strategies, such as proposing a 50% reduction in fertilizer losses and a 20% reduction in fertilizer consumption by 2030, are expected to drive innovation in the sustainable agrochemicals market. For further information on this analysis, please click here.
The term “bioeconomy” covers multiple scientific fields and interrelated perspectives highlighting biotechnology, bio-resources, and bio-ecology (Bugge et al., Higher Education Institutes Digivision 2030. If we don't change, we don't grow. . Gail Sheehy. Introduction . The macro level context also has an impact. Digital disruption.
The landscape of global molecular biomarkers is rapidly evolving, driven by advancements in biotechnology and the increasing demand for personalized medicine. Organizations integrating digital health solutions, AI analytics, and direct-to-patient diagnostics will be best positioned for success by 2030 and beyond. Want deeper insights?
The pharmaceutical and biotechnology industries are at the cusp of a transformative era in 2025, driven by cutting-edge innovation, evolving regulations, and increasing market pressures. By 2030, the RLT market is projected to reach $13.07 billion by 2030. The market for RLT is set for exponential growth. billion in sales.
million by 2030, emphasizing the need for early and accurate diagnostics. Elabscience Biotechnology, Inc., Download our full analysis on Cardiac Biomarkers Diagnostics. Click here to download According to the World Health Organization (WHO), CVD-related deaths are projected to reach 23.3 Quanterix, Response Biomedical Corp.,
We organize all of the trending information in your field so you don't have to. Join 61,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content